Performance of Cleveland, Mehta, and Simplified Renal Index scores for predicting dialysis-requiring acute kidney injury after aortic vs. non-aortic cardiac surgery (2006-2023, 6160 patients)

克利夫兰评分、梅塔评分和简化肾脏指数评分在预测主动脉心脏手术与非主动脉心脏手术后需要透析的急性肾损伤方面的表现(2006-2023 年,6160 例患者)

阅读:1

Abstract

Acute kidney injury requiring renal replacement therapy (RRT-AKI) is a serious complication after cardiac surgery, especially in aortic procedures. Validated risk models, such as the Cleveland Clinic Score, Mehta tool, and Simplified Renal Index (SRI) are widely applied, but their performance in predicting after aortic versus non-aortic cardiac surgery remains uncertain. We conducted a retrospective cohort study of 6,160 patients undergoing cardiac surgery (1,002 aortic and 5,158 non-aortic) (2006-2023) at a teaching hospital in Hong Kong. Predictive performance of the risk scores were assessed using the area under the receiver operating characteristic curve (AUC). Differences in AUC were assessed using DeLong's test. Hosmer-Lemeshow goodness-of-fit test was used to assess calibration. In this cohort, 3.2% developed RRT-AKI. RRT-AKI was more common after aortic surgery than non-aortic surgery (6.7 vs. 2.5%; p = <.001). Thirty-day mortality reached 40% in patients with acute kidney injury requiring renal replacement therapy after cardiac surgery. In the non-aortic surgery cohort, the three scores only showed moderate discriminatory power (worse than original cohorts) and good calibration: 0.77 (95% CI, 0.72-0.81) and p = .62 (Cleveland); 0.75 (95% CI, 0.70-0.80) and p = .10 (Mehta); and 0.75 (95% CI, 0.71-0.79) and p = .65 (SRI). In the aortic surgery cohort, there was only moderate discriminatory power and good calibration: AUC 0.70 (95% CI, 0.63-0.77) and p = .57 (Cleveland); 0.67 (95% CI, 0.59-0.74) and p = .67 (Mehta); 0.65 (95% CI, 0.58-0.72) and p = .79 (SRI). Currently established risk scores only have moderate discriminatory power (range of AUC 0.65-0.77) to predict RRT-AKI after both cardiac and aortic surgery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。